Agilent Early Career Professor Award Presented to Christoph Thaiss at University of Pennsylvania
September 07 2018 - 11:00AM
Business Wire
Penn microbiologist recognized for groundbreaking microbiome
research
Agilent Technologies Inc. (NYSE: A) today announced that the
winner of the 2018 Agilent Early Career Professor Award is
Christoph Thaiss, Ph.D., assistant professor of microbiology in the
Perelman School of Medicine at the University of Pennsylvania.
Dr. Thaiss’s research focuses on the microbiome and how it
mediates the response of its host to environmental cues, which
strongly influences the organism’s health and disease states. This
research is also leading to work on potential translational
outcomes, such as innovative therapies for common human
diseases.
“We are very happy to support Dr. Thaiss and his transformative
microbiome research," said Jack Wenstrand, director of University
Relations and External Research at Agilent. “His focus to address
fundamental aspects of the interactions of the human microbiome and
its host, in the context of response to environmental clues has
been extraordinary. The potential of his research is immense.”
“It is a tremendous honor for my lab and myself to receive this
award,” said Dr. Thaiss. “It will allow us to pursue the
translational potential of our findings and to explore new areas of
host-microbiome interactions that are completely unstudied so
far.”
Dr. Thaiss has made seminal contributions to the field of
host-microbiome interactions. Using multi-omics approaches—from
sequencing-based metagenomics to mass spectrometry-based
metabolomics analysis, coupled with in vitro and in vivo
systems—his team studies the prokaryotic microbiome, its eukaryotic
host, and their interplay.
This work has resulted in the discovery that the intestinal
microbiome undergoes diurnal rhythms that strongly influence the
circadian biology of the host. Dr. Thaiss has also identified
memory-like signatures in the microbiome that predispose an obese
host to recurrent weight regain. Additionally, his work recently
demonstrated that hyperglycemia causes loss of intestinal barrier
integrity and microbiota containment, providing a mechanism for the
association between obesity and chronic multi-organ
inflammation.
Numerous modern human diseases, including obesity and diabetes,
neurodegeneration, and cancer, are strongly influenced by
environmental factors. Dr. Thaiss’s research seeks a deeper
understanding of how humans and their microbiota sense these
environmental factors and how their integrative activity controls
tissue homeostasis and inflammation.
The Agilent Early Career Professor Award was established in
2008. Through this award, Agilent seeks to recognize the
achievements of academic researchers in the initial stages of their
careers and to support and develop strong collaborative
relationships at the beginning of their professional lives. There
is no commitment to use the award for Agilent products, nor any
obligations regarding the research directions for which the award
is used.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics, and applied chemical markets. With more than
50 years of insight and innovation, Agilent instruments, software,
services, solutions, and people provide trusted answers to
customers' most challenging questions. The company generated
revenues of $4.47 billion in fiscal 2017 and employs 14,200 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
our Newsroom.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180907005237/en/
Agilent TechnologiesNaomi Goumillout,
+1-781-266-2819naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Sep 2023 to Sep 2024